MarketPulse

regulatory milestones

3 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Oculis Holding Ag

Oculis to Showcase Late-Stage Pipeline at ARVO 2026 Amid Key DME Trial Readout

Oculis will present its ophthalmology pipeline at ARVO 2026, with Phase 3 results for lead DME candidate OCS-01 expected in June.
OCSOCSAWclinical trialsdiabetic macular edema
The Motley FoolThe Motley Fool··Seena Hassouna

Pharvaris Director's Stock Sale Pales Against Upcoming Clinical Catalysts

Pharvaris director's modest 1.80% stock sale matters less than upcoming Phase 3 data and FDA submission catalysts arriving in 2026.
PHVSclinical-stage biotechPhase 3 trial
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Oculis Names Veterans Legal Executive as CLO Amid Clinical Pipeline Expansion

Oculis appoints seasoned legal executive Katie Kazem as Chief Legal Officer to strengthen governance as it advances clinical pipeline with late-stage therapeutic candidates.
OCSOCSAWsecurities lawclinical trials